Jinhe Biotechnology CO., LTD.

Equities

002688

CNE100001HK7

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
3.82 CNY +0.79% Intraday chart for Jinhe Biotechnology CO., LTD. +6.70% -20.58%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Tranche Update on Jinhe Biotechnology CO., LTD.'s Equity Buyback Plan announced on February 6, 2024. CI
Jinhe Biotechnology CO., LTD. announces an Equity Buyback for CNY 100 million worth of its shares. CI
Jinhe Biotechnology CO., LTD. authorizes a Buyback Plan. CI
Jinhe Biotechnology Chairman Proposes Buyback of Up to 100 Million Yuan Shares MT
Jinhe Biotechnology Gets Nod for Live Brucellosis Vaccine MT
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Jinhe Biotechnology Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 05 June 2023 CI
Jinhe Biotechnology CO., LTD. announced that it expects to receive CAD 124.8 million in funding from Jinhe Youben Biological Products Co., Ltd. CI
Jinhe Biotechnology CO., LTD. Announces Board Election CI
Jinhe Biotechnology CO., LTD. Approves Cash Dividend (Tax Included) for 2022 CI
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Jinhe Biotechnology Co., Ltd. Announces Final Profit Distribution Proposal for 2022 CI
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Tranche Update on Jinhe Biotechnology CO., LTD.'s Equity Buyback Plan announced on May 26, 2022. CI
Jinhe Biotechnology to Take Full Control of Environmental Protection Firm For $46 Million MT
Jinhe Biotechnology CO., LTD. agreed to acquire 49% stake in Inner Mongolia Jinhe Environmental Protection Technology Co., Ltd. from and others for CNY 318 million. CI
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Tranche Update on Jinhe Biotechnology CO., LTD.'s Equity Buyback Plan announced on May 26, 2022. CI
Jinhe Biotechnology CO., LTD. commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on May 12, 2022. CI
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Jinhe Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Jinhe Biotechnology CO., LTD. announced that it has received CNY 819.999998 million in funding from a group of investors CI
Chart Jinhe Biotechnology CO., LTD.
More charts
Jinhe Biotechnology CO., LTD. is a China-based company principally engaged in the research, development, production and sale of pharmaceutical feed additives. The Company's main products include animal feed additives, veterinary drug additives, veterinary vaccines and veterinary drugs. The Company is also involved in processing of corn starch, as well as wastewater treatment business. The Company distributes its products in domestic market and to overseas markets.
Calendar
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 002688 Stock
  4. News Jinhe Biotechnology CO., LTD.
  5. Jinhe Biotechnology Gets Nod for Live Brucellosis Vaccine